Europe Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type (Fetal Bovine Serum, Adult Bovine Serum, Porcine Serum, Horse Serum, Other Animal Serum); By Application (Bioproduction, Drug Discovery, Tissue Engineering and Regenerative Medicines, Toxicity Testing, Academic Research); and Country

Market Introduction

The cell line can be defined as cell culture, wherein the cells multiply by adapting in growing medium and space for growth. The cell line development serum market growth is mainly attributed to the serum as a source of growth and adhesion factors, lipids, hormones, and minerals for cells' culture in basal media. The serum serves as a carrier for enzymes, micronutrients, lipids, and trace elements into the cell and also regulates cell membrane permeability.

Market Overview and Dynamics

The Europe cell line development serum market is expected to reach US$ 422.61 Mn in 2027 from US$ 268.68 Mn in 2019. The market is estimated to grow with a CAGR of 5.9% from 2020 to 2027. Key factors that are driving growth of the Europe cell line development serum market are increasing adoption of regenerative medicines, rising prevalence of cancer across the globe and increasing investments in R&D by pharmaceutical and biotechnology companies.

Key Market Segments

Based on type, the Europe cell line development serum market is segmented into fetal bovine serum, porcine serum, adult bovine serum, horse serum, and other animal serum. The fetal bovine serum segment held a significant share of the market and is estimated to register the highest CAGR during the forecast period.

Based on application, the Europe cell line development serum market is segmented into tissue engineering and regenerative medicines, academic research, drug discovery, toxicity testing, and bioproduction. In 2019, the bioproduction segment held the largest share of the market; whereas, the drug discovery segment is anticipated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

Some of the primary and secondary sources associated with this report on the Europe cell line development serum market are European Forum for Industrial Biotechnology and the Bioeconomy Alliance (EFIBA); European Collection of Cell Cultures (ECACC); Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS); and World Health Organization (WHO); among others.

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of the Europe cell line development serum market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Europe cell line development serum market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe cell line development serum market.

EUROPE CELL LINE DEVELOPMENT SERUM MARKET SEGMENTATION

By Type

• Fetal Bovine Serum
• Adult Bovine Serum
• Porcine Serum
• Horse Serum
• Other Animal Serum

By Application

• Bioproduction
• Drug Discovery
• Tissue Engineering and Regenerative Medicines
• Toxicity Testing
• Academic Research

By Country

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe

Company Profiles

• Lonza  
• Thermo Fisher Scientific Inc.
• Sigma-Aldrich Corporation (Merck KGaA)
• Cytiva (Danaher)
• Corning Incorporated
• European Collection of Cell Cultures (ECACC)
• WuXi AppTec
• American Type Culture Collection (ATCC)

1. Lonza  
2. Thermo Fisher Scientific Inc.
3. Sigma-Aldrich Corporation (Merck KGaA)
4. Cytiva (Danaher)
5. Corning Incorporated
6. European Collection of Cell Cultures (ECACC)
7. WuXi AppTec
8. American Type Culture Collection (ATCC)

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe cell line development serum market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Europe cell line development serum market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.